• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与慢性自发性荨麻疹患者疾病严重程度和缓解时间相关的因素。

Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria.

作者信息

Sánchez-Borges M, Caballero-Fonseca F, Capriles-Hulett A, González-Aveledo L, Maurer M

机构信息

Allergy and Clinical Immunology Department, Centro Médico Docente La Trinidad, Caracas, Venezuela.

Allergy Service, Clínica El Avila, Caracas, Venezuela.

出版信息

J Eur Acad Dermatol Venereol. 2017 Jun;31(6):964-971. doi: 10.1111/jdv.14221. Epub 2017 Apr 4.

DOI:10.1111/jdv.14221
PMID:28299827
Abstract

Biomarkers useful for the evaluation and management of patients with chronic spontaneous urticaria (CSU) are not currently available. A review of various clinical and laboratory markers that have been studied to assess their value for determining the severity or predicting the evolution of disease in adult patients with CSU was carried out. A search of the medical literature on PubMed and MEDLINE including the terms urticaria, chronic urticaria, chronic idiopathic urticaria, CSU, severity, prognosis and treatment was performed. Based on our review of the literature, among the clinical markers studied, higher age at onset, being female, long disease duration and aspirin/NSAID hypersensitivity may be linked to both severe CSU and a long time to spontaneous remission. In addition, a positive autologous serum skin test (ASST) may be associated with severe CSU, and comorbidity of inducible urticaria and concomitant recurrent angio-oedema may be linked to longer CSU duration. Potential biomarkers of CSU severity and/or duration include basophil numbers and susceptibility to activation, inflammatory markers, markers of activation of the extrinsic coagulation pathway, immunoglobulin E and vitamin D. Although the described markers are promising, further studies on representative and well-characterized patient populations are needed to determine the value of these clinical and biological markers for predicting the severity and course of disease in patients with CSU.

摘要

目前尚无用于评估和管理慢性自发性荨麻疹(CSU)患者的生物标志物。我们对各种临床和实验室标志物进行了综述,这些标志物已被研究以评估其在确定成年CSU患者疾病严重程度或预测疾病进展方面的价值。我们在PubMed和MEDLINE上搜索了医学文献,搜索词包括荨麻疹、慢性荨麻疹、慢性特发性荨麻疹、CSU、严重程度、预后和治疗。基于我们对文献的综述,在所研究的临床标志物中,发病年龄较大、女性、病程长以及阿司匹林/非甾体抗炎药超敏反应可能与严重CSU和自发缓解时间长有关。此外,自体血清皮肤试验(ASST)阳性可能与严重CSU相关,诱导性荨麻疹合并复发性血管性水肿可能与CSU病程较长有关。CSU严重程度和/或病程的潜在生物标志物包括嗜碱性粒细胞数量及其活化敏感性、炎症标志物、外源性凝血途径活化标志物、免疫球蛋白E和维生素D。尽管所描述标志物很有前景,但仍需要对具有代表性且特征明确的患者群体进行进一步研究,以确定这些临床和生物学标志物在预测CSU患者疾病严重程度和病程方面的价值。

相似文献

1
Factors linked to disease severity and time to remission in patients with chronic spontaneous urticaria.与慢性自发性荨麻疹患者疾病严重程度和缓解时间相关的因素。
J Eur Acad Dermatol Venereol. 2017 Jun;31(6):964-971. doi: 10.1111/jdv.14221. Epub 2017 Apr 4.
2
The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria.急性自发性荨麻疹的临床和实验室特征及其向慢性自发性荨麻疹的进展。
Allergy Asthma Proc. 2016 Sep;37(5):394-9. doi: 10.2500/aap.2016.37.3971.
3
Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity.慢性自发性荨麻疹中嗜碱性粒细胞CD63的表达:与过敏致敏、血清自身反应性及嗜碱性粒细胞反应性的相关性
J Eur Acad Dermatol Venereol. 2017 Mar;31(3):463-468. doi: 10.1111/jdv.13912. Epub 2016 Sep 5.
4
Biomarkers of treatment efficacy in patients with chronic spontaneous urticaria.慢性自发性荨麻疹患者治疗疗效的生物标志物
Eur Ann Allergy Clin Immunol. 2018 Jan;50(1):5-9. doi: 10.23822/EurAnnACI.1764-1489.24.
5
In chronic spontaneous urticaria, high numbers of dermal endothelial cells, but not mast cells, are linked to recurrent angio-oedema.在慢性自发性荨麻疹中,大量真皮内皮细胞与复发性血管性水肿有关,而不是肥大细胞。
Clin Exp Dermatol. 2018 Mar;43(2):131-136. doi: 10.1111/ced.13254. Epub 2017 Oct 24.
6
Thyroid Autoimmunity and Autoimmunity in Chronic Spontaneous Urticaria Linked to Disease Severity, Therapeutic Response, and Time to Remission in Patients with Chronic Spontaneous Urticaria.甲状腺自身免疫与慢性自发性荨麻疹自身免疫与疾病严重程度、治疗反应及慢性自发性荨麻疹患者缓解时间相关。
Biomed Res Int. 2018 Nov 1;2018:9856843. doi: 10.1155/2018/9856843. eCollection 2018.
7
Hashimoto's disease is a frequent comorbidity and an exacerbating factor of chronic spontaneous urticaria.桥本氏病是慢性自发性荨麻疹常见的合并症及加重因素。
Allergol Immunopathol (Madr). 2015 May-Jun;43(3):249-53. doi: 10.1016/j.aller.2014.02.007. Epub 2014 Aug 1.
8
C-reactive protein is linked to disease activity, impact, and response to treatment in patients with chronic spontaneous urticaria.C 反应蛋白与慢性自发性荨麻疹患者的疾病活动度、影响和治疗反应有关。
Allergy. 2018 Apr;73(4):940-948. doi: 10.1111/all.13352. Epub 2017 Dec 7.
9
Different expression patterns of plasma Th1-, Th2-, Th17- and Th22-related cytokines correlate with serum autoreactivity and allergen sensitivity in chronic spontaneous urticaria.慢性自发性荨麻疹患者的血浆 Th1、Th2、Th17 和 Th22 相关细胞因子表达模式不同,与血清自身反应性和变应原敏感性相关。
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):441-448. doi: 10.1111/jdv.14541. Epub 2017 Sep 14.
10
Autologous serum and plasma skin test to predict 2-year outcome in chronic spontaneous urticaria.自体血清和血浆皮肤试验预测慢性自发性荨麻疹的2年预后
Asia Pac Allergy. 2016 Oct;6(4):226-235. doi: 10.5415/apallergy.2016.6.4.226. Epub 2016 Oct 31.

引用本文的文献

1
Chronic inducible urticaria - having more than one is common and clinically relevant.慢性诱导性荨麻疹——存在多种类型很常见且具有临床相关性。
Front Immunol. 2025 Jun 30;16:1584771. doi: 10.3389/fimmu.2025.1584771. eCollection 2025.
2
Cluster Analysis of Clinical Remission and Relapse Patterns in Chronic Urticaria: Results from the PREDICT-CU Study.慢性荨麻疹临床缓解与复发模式的聚类分析:PREDICT-CU研究结果
Dermatol Ther (Heidelb). 2025 Apr;15(4):933-948. doi: 10.1007/s13555-025-01376-4. Epub 2025 Mar 17.
3
Assesment of Salivary and Serum Levels of HBD2 in Patients with Chronic Angioedema.
慢性血管性水肿患者唾液和血清中HBD2水平的评估。
J Clin Med. 2024 Dec 11;13(24):7552. doi: 10.3390/jcm13247552.
4
Neutrophil/Lymphocyte Ratio as a Biomarker of Response to H1-Antihistamine Therapy in Patients with Chronic Spontaneous Urticaria.中性粒细胞/淋巴细胞比值作为慢性自发性荨麻疹患者对H1抗组胺药治疗反应的生物标志物
Indian J Dermatol. 2024 Sep-Oct;69(5):367-370. doi: 10.4103/ijd.ijd_558_22. Epub 2024 Oct 29.
5
Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies.精准皮肤病学:分子生物标志物与个性化治疗综述
Curr Issues Mol Biol. 2024 Mar 30;46(4):2975-2990. doi: 10.3390/cimb46040186.
6
Different doses and courses of omalizumab for patients with chronic spontaneous urticaria: A systematic review with meta-analysis and trial sequential analysis.不同剂量和疗程的奥马珠单抗治疗慢性自发性荨麻疹患者:一项系统评价及荟萃分析和试验序贯分析
World Allergy Organ J. 2024 Apr 10;17(4):100898. doi: 10.1016/j.waojou.2024.100898. eCollection 2024 Apr.
7
Five-Membered Nitrogen Heterocycles Angiotensin-Converting Enzyme (ACE) Inhibitors Induced Angioedema: An Underdiagnosed Condition.五元氮杂环类血管紧张素转换酶(ACE)抑制剂诱发的血管性水肿:一种诊断不足的病症。
Pharmaceuticals (Basel). 2024 Mar 10;17(3):360. doi: 10.3390/ph17030360.
8
Risk calculator of the clinical response to antihistamines in chronic urticaria: Development and internal validation.慢性荨麻疹抗组胺治疗临床应答风险计算器的建立和内部验证。
PLoS One. 2024 Feb 23;19(2):e0295791. doi: 10.1371/journal.pone.0295791. eCollection 2024.
9
A global perspective on stepping down chronic spontaneous urticaria treatment: Results of the Urticaria Centers of Reference and Excellence SDown-CSU study.慢性自发性荨麻疹治疗逐步减量的全球视角:卓越荨麻疹参考中心SDown-CSU研究结果
Clin Transl Allergy. 2024 Feb;14(2):e12343. doi: 10.1002/clt2.12343.
10
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don't Know.慢性自发性荨麻疹的降级治疗:已知与未知。
Am J Clin Dermatol. 2023 May;24(3):397-404. doi: 10.1007/s40257-023-00761-z. Epub 2023 Feb 22.